#METABOLOMICS WORKBENCH Durva_Panchal_20241025_024317 DATATRACK_ID:5315 STUDY_ID:ST003542 ANALYSIS_ID:AN005816 PROJECT_ID:PR002178 VERSION 1 CREATED_ON October 29, 2024, 9:43 am #PROJECT PR:PROJECT_TITLE Dysregulated Follicular Fluid Metabolism in Women with Unexplained Infertility PR:PROJECT_TYPE HILIC and RPLC-Based Untargeted LC-MS/MS PR:PROJECT_SUMMARY Research Question: Are there specific metabolomic alterations in the Follicular PR:PROJECT_SUMMARY fluid (FF) of women with unexplained infertility (UI)? Study Design: This PR:PROJECT_SUMMARY case-control study included 20 women undergoing in-vitro fertilization (IVF), PR:PROJECT_SUMMARY comparing 10 women diagnosed with UI to 10 control women whose male partners had PR:PROJECT_SUMMARY abnormal semen parameters. FF samples were collected during oocyte retrieval and PR:PROJECT_SUMMARY analysed using hydrophilic interaction liquid chromatography and reversed-phase PR:PROJECT_SUMMARY liquid chromatography, coupled with tandem mass spectrometry (MS/MS) on a Q-TOF PR:PROJECT_SUMMARY mass spectrometer. Metabolites were identified using XCMS Online and PR:PROJECT_SUMMARY MetaboAnalyst, followed by pathway enrichment analysis via the KEGG database. PR:PROJECT_SUMMARY Statistical analyses including OPLS-DA and ROC analysis assessed their PR:PROJECT_SUMMARY diagnostic potential. Metabolite levels were correlated with clinical PR:PROJECT_SUMMARY parameters, including embryo development rates, oocyte maturation, and IVF PR:PROJECT_SUMMARY outcomes. Results: In women with UI, 12 metabolites, including Diacylglycerols, PR:PROJECT_SUMMARY Phosphatidic acids, Vitamin D3 glucosiduronate, PR:PROJECT_SUMMARY 1α-hydroxy-2β-(5-hydroxypentoxy) vitamin D3, Asparginyl-Asparagine, PR:PROJECT_SUMMARY Lithocholic acid, Leu-Pro-Ala-Ser-Phe, Triacylglycerols, Phosphatidyl choline, PR:PROJECT_SUMMARY Phosphatidylethanolamine and Lactosyl ceramide were significantly decreased, PR:PROJECT_SUMMARY while Ile-Lys-Val-Val was significantly increased compared to controls. These PR:PROJECT_SUMMARY metabolites were linked to glycerophospholipid metabolism, glycerolipid PR:PROJECT_SUMMARY metabolism, and steroid synthesis pathways. PLS-DA, OPLS-DA, and ROC analysis PR:PROJECT_SUMMARY indicated high diagnostic performance, with AUC values exceeding 0.8. PR:PROJECT_SUMMARY Additionally, Vitamin D3 glucosiduronate levels negatively correlated with PR:PROJECT_SUMMARY embryo development rates, while Asparginyl-Asparagine levels demonstrated a PR:PROJECT_SUMMARY positive correlation with the MII oocyte rate. Conclusion: This study PR:PROJECT_SUMMARY constitutes the first comprehensive characterization of metabolic dysregulation PR:PROJECT_SUMMARY in the FF of women with UI, offering novel insights into the underlying PR:PROJECT_SUMMARY mechanisms contributing to this condition and advocates for routine assessment PR:PROJECT_SUMMARY of vitamin D3 levels in serum/FF of these women. PR:INSTITUTE ICMR - National Institute for Research in Reproductive and Child Health PR:DEPARTMENT Gamete Immunobiology PR:LAST_NAME Panchal PR:FIRST_NAME Durva PR:ADDRESS J.M. Street, Parel, Mumbai, Maharashtra, 400012, India PR:EMAIL durva_gib@nirrh.res.in PR:PHONE 022-2419-2005 #STUDY ST:STUDY_TITLE Dysregulated Follicular Fluid Metabolism in Women with Unexplained Infertility ST:STUDY_TYPE HILIC and RPLC based Untargeted LC-MS/MS ST:STUDY_SUMMARY Research Question: Are there specific metabolomic alterations in the Follicular ST:STUDY_SUMMARY fluid (FF) of women with unexplained infertility (UI)? Study Design: This ST:STUDY_SUMMARY case-control study included 20 women undergoing in-vitro fertilization (IVF), ST:STUDY_SUMMARY comparing 10 women diagnosed with UI to 10 control women whose male partners had ST:STUDY_SUMMARY abnormal semen parameters. FF samples were collected during oocyte retrieval and ST:STUDY_SUMMARY analysed using hydrophilic interaction liquid chromatography and reversed-phase ST:STUDY_SUMMARY liquid chromatography, coupled with tandem mass spectrometry (MS/MS) on a Q-TOF ST:STUDY_SUMMARY mass spectrometer. Metabolites were identified using XCMS Online and ST:STUDY_SUMMARY MetaboAnalyst, followed by pathway enrichment analysis via the KEGG database. ST:STUDY_SUMMARY Statistical analyses including OPLS-DA and ROC analysis assessed their ST:STUDY_SUMMARY diagnostic potential. Metabolite levels were correlated with clinical ST:STUDY_SUMMARY parameters, including embryo development rates, oocyte maturation, and IVF ST:STUDY_SUMMARY outcomes. Results: In women with UI, 12 metabolites, including Diacylglycerols, ST:STUDY_SUMMARY Phosphatidic acids, Vitamin D3 glucosiduronate, ST:STUDY_SUMMARY 1α-hydroxy-2β-(5-hydroxypentoxy) vitamin D3, Asparginyl-Asparagine, ST:STUDY_SUMMARY Lithocholic acid, Leu-Pro-Ala-Ser-Phe, Triacylglycerols, Phosphatidyl choline, ST:STUDY_SUMMARY Phosphatidylethanolamine and Lactosyl ceramide were significantly decreased, ST:STUDY_SUMMARY while Ile-Lys-Val-Val was significantly increased compared to controls. These ST:STUDY_SUMMARY metabolites were linked to glycerophospholipid metabolism, glycerolipid ST:STUDY_SUMMARY metabolism, and steroid synthesis pathways. PLS-DA, OPLS-DA, and ROC analysis ST:STUDY_SUMMARY indicated high diagnostic performance, with AUC values exceeding 0.8. ST:STUDY_SUMMARY Additionally, Vitamin D3 glucosiduronate levels negatively correlated with ST:STUDY_SUMMARY embryo development rates, while Asparginyl-Asparagine levels demonstrated a ST:STUDY_SUMMARY positive correlation with the MII oocyte rate. Conclusion: This study ST:STUDY_SUMMARY constitutes the first comprehensive characterization of metabolic dysregulation ST:STUDY_SUMMARY in the FF of women with UI, offering novel insights into the underlying ST:STUDY_SUMMARY mechanisms contributing to this condition and advocates for routine assessment ST:STUDY_SUMMARY of vitamin D3 levels in serum/FF of these women. ST:INSTITUTE ICMR - National Institute for Research in Reproductive and Child Health ST:DEPARTMENT Gamete Immunobiology ST:LAST_NAME Panchal ST:FIRST_NAME Durva ST:ADDRESS ICMR - NIRRCH, J.M.Street, Parel, Mumbai, India ST:EMAIL durva_gib@nirrh.res.in ST:PHONE 9619565514 ST:NUM_GROUPS 2 ST:TOTAL_SUBJECTS 20 ST:NUM_FEMALES 20 (10 per group) ST:STUDY_COMMENTS This case-control study included 20 women undergoing in-vitro fertilization ST:STUDY_COMMENTS (IVF), comprising 10 women diagnosed with unexplained infertility (UI) and 10 ST:STUDY_COMMENTS control women whose male partners exhibited abnormal semen parameters. The aim ST:STUDY_COMMENTS was to investigate metabolic differences in the follicular fluid of these ST:STUDY_COMMENTS groups, contributing to a deeper understanding of factors influencing ST:STUDY_COMMENTS reproductive outcomes. ST:PUBLICATIONS None #SUBJECT SU:SUBJECT_TYPE Human SU:SUBJECT_SPECIES Homo sapiens SU:TAXONOMY_ID 9606 SU:AGE_OR_AGE_RANGE 22 - 40 years SU:GENDER Female #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data SUBJECT_SAMPLE_FACTORS S1 H_Control-1 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Positive_Sample1.mzML SUBJECT_SAMPLE_FACTORS S2 H_Control-2 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Positive_Sample2.mzML SUBJECT_SAMPLE_FACTORS S3 H_Control-3 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Positive_Sample3.mzML SUBJECT_SAMPLE_FACTORS S4 H_Control-4 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Positive_Sample4.mzML SUBJECT_SAMPLE_FACTORS S5 H_Control-5 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Positive_Sample5.mzML SUBJECT_SAMPLE_FACTORS S6 H_Control-6 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Positive_Sample6.mzML SUBJECT_SAMPLE_FACTORS S7 H_Control-7 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Positive_Sample7.mzML SUBJECT_SAMPLE_FACTORS S8 H_Control-8 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Positive_Sample8.mzML SUBJECT_SAMPLE_FACTORS S9 H_Control-9 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Positive_Sample9.mzML SUBJECT_SAMPLE_FACTORS S10 H_Control-10 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Positive_Sample10.mzML SUBJECT_SAMPLE_FACTORS S11 H_UI-1 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Positive_Sample1.mzML SUBJECT_SAMPLE_FACTORS S12 H_UI-2 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Positive_Sample2.mzML SUBJECT_SAMPLE_FACTORS S13 H_UI-3 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Positive_Sample3.mzML SUBJECT_SAMPLE_FACTORS S14 H_UI-4 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Positive_Sample4.mzML SUBJECT_SAMPLE_FACTORS S15 H_UI-5 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Positive_Sample5.mzML SUBJECT_SAMPLE_FACTORS S16 H_UI-6 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Positive_Sample6.mzML SUBJECT_SAMPLE_FACTORS S17 H_UI-7 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Positive_Sample7.mzML SUBJECT_SAMPLE_FACTORS S18 H_UI-8 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Positive_Sample8.mzML SUBJECT_SAMPLE_FACTORS S19 H_UI-9 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Positive_Sample9.mzML SUBJECT_SAMPLE_FACTORS S20 H_UI-10 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Positive_Sample10.mzML SUBJECT_SAMPLE_FACTORS S21 H_Control-ve-1 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Negative_Sample1.mzML SUBJECT_SAMPLE_FACTORS S22 H_Control-ve-2 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Negative_Sample2.mzML SUBJECT_SAMPLE_FACTORS S23 H_Control-ve-3 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Negative_Sample3.mzML SUBJECT_SAMPLE_FACTORS S24 H_Control-ve-4 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Negative_Sample4.mzML SUBJECT_SAMPLE_FACTORS S25 H_Control-ve-5 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Negative_Sample5.mzML SUBJECT_SAMPLE_FACTORS S26 H_Control-ve-6 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Negative_Sample6.mzML SUBJECT_SAMPLE_FACTORS S27 H_Control-ve-7 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Negative_Sample7.mzML SUBJECT_SAMPLE_FACTORS S28 H_Control-ve-8 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Negative_Sample8.mzML SUBJECT_SAMPLE_FACTORS S29 H_Control-ve-9 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Negative_Sample9.mzML SUBJECT_SAMPLE_FACTORS S30 H_Control-ve-10 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_HILIC_Negative_Sample10.mzML SUBJECT_SAMPLE_FACTORS S31 H_UI-ve-1 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Negative_Sample1.mzML SUBJECT_SAMPLE_FACTORS S32 H_UI-ve-2 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Negative_Sample2.mzML SUBJECT_SAMPLE_FACTORS S33 H_UI-ve-3 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Negative_Sample3.mzML SUBJECT_SAMPLE_FACTORS S34 H_UI-ve-4 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Negative_Sample4.mzML SUBJECT_SAMPLE_FACTORS S35 H_UI-ve-5 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Negative_Sample5.mzML SUBJECT_SAMPLE_FACTORS S36 H_UI-ve-6 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Negative_Sample6.mzML SUBJECT_SAMPLE_FACTORS S37 H_UI-ve-7 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Negative_Sample7.mzML SUBJECT_SAMPLE_FACTORS S38 H_UI-ve-8 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Negative_Sample8.mzML SUBJECT_SAMPLE_FACTORS S39 H_UI-ve-9 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Negative_Sample9.mzML SUBJECT_SAMPLE_FACTORS S40 H_UI-ve-10 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_HILIC_Negative_Sample10.mzML SUBJECT_SAMPLE_FACTORS S41 R_Control-1 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Positive_Sample1.mzML SUBJECT_SAMPLE_FACTORS S42 R_Control-2 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Positive_Sample2.mzML SUBJECT_SAMPLE_FACTORS S43 R_Control-3 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Positive_Sample3.mzML SUBJECT_SAMPLE_FACTORS S44 R_Control-4 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Positive_Sample4.mzML SUBJECT_SAMPLE_FACTORS S45 R_Control-5 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Positive_Sample5.mzML SUBJECT_SAMPLE_FACTORS S46 R_Control-6 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Positive_Sample6.mzML SUBJECT_SAMPLE_FACTORS S47 R_Control-7 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Positive_Sample7.mzML SUBJECT_SAMPLE_FACTORS S48 R_Control-8 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Positive_Sample8.mzML SUBJECT_SAMPLE_FACTORS S49 R_Control-9 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Positive_Sample9.mzML SUBJECT_SAMPLE_FACTORS S50 R_Control-10 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Positive_Sample10.mzML SUBJECT_SAMPLE_FACTORS S51 R_UI-1 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Positive_Sample1.mzML SUBJECT_SAMPLE_FACTORS S52 R_UI-2 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Positive_Sample2.mzML SUBJECT_SAMPLE_FACTORS S53 R_UI-3 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Positive_Sample3.mzML SUBJECT_SAMPLE_FACTORS S54 R_UI-4 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Positive_Sample4.mzML SUBJECT_SAMPLE_FACTORS S55 R_UI-5 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Positive_Sample5.mzML SUBJECT_SAMPLE_FACTORS S56 R_UI-6 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Positive_Sample6.mzML SUBJECT_SAMPLE_FACTORS S57 R_UI-7 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Positive_Sample7.mzML SUBJECT_SAMPLE_FACTORS S58 R_UI-8 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Positive_Sample8.mzML SUBJECT_SAMPLE_FACTORS S59 R_UI-9 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Positive_Sample9.mzML SUBJECT_SAMPLE_FACTORS S60 R_UI-10 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Positive_Sample10.mzML SUBJECT_SAMPLE_FACTORS S61 R_Control-ve-1 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Negative_Sample1.mzML SUBJECT_SAMPLE_FACTORS S62 R_Control-ve-2 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Negative_Sample2.mzML SUBJECT_SAMPLE_FACTORS S63 R_Control-ve-3 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Negative_Sample3.mzML SUBJECT_SAMPLE_FACTORS S64 R_Control-ve-4 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Negative_Sample4.mzML SUBJECT_SAMPLE_FACTORS S65 R_Control-ve-5 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Negative_Sample5.mzML SUBJECT_SAMPLE_FACTORS S66 R_Control-ve-6 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Negative_Sample6.mzML SUBJECT_SAMPLE_FACTORS S67 R_Control-ve-7 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Negative_Sample7.mzML SUBJECT_SAMPLE_FACTORS S68 R_Control-ve-8 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Negative_Sample8.mzML SUBJECT_SAMPLE_FACTORS S69 R_Control-ve-9 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Negative_Sample9.mzML SUBJECT_SAMPLE_FACTORS S70 R_Control-ve-10 Sample source:Follicular fluid | Fertility status:Control RAW_FILE_NAME(Raw file name)=Control_RPLC_Negative_Sample10.mzML SUBJECT_SAMPLE_FACTORS S71 R_UI-ve-1 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Negative_Sample1.mzML SUBJECT_SAMPLE_FACTORS S72 R_UI-ve-2 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Negative_Sample2.mzML SUBJECT_SAMPLE_FACTORS S73 R_UI-ve-3 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Negative_Sample3.mzML SUBJECT_SAMPLE_FACTORS S74 R_UI-ve-4 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Negative_Sample4.mzML SUBJECT_SAMPLE_FACTORS S75 R_UI-ve-5 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Negative_Sample5.mzML SUBJECT_SAMPLE_FACTORS S76 R_UI-ve-6 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Negative_Sample6.mzML SUBJECT_SAMPLE_FACTORS S77 R_UI-ve-7 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Negative_Sample7.mzML SUBJECT_SAMPLE_FACTORS S78 R_UI-ve-8 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Negative_Sample8.mzML SUBJECT_SAMPLE_FACTORS S79 R_UI-ve-9 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Negative_Sample9.mzML SUBJECT_SAMPLE_FACTORS S80 R_UI-ve-10 Sample source:Follicular fluid | Fertility status:UI RAW_FILE_NAME(Raw file name)=Unexplained Infertility_RPLC_Negative_Sample10.mzML #COLLECTION CO:COLLECTION_SUMMARY All participants underwent controlled ovulation stimulation using GnRH CO:COLLECTION_SUMMARY antagonist protocols (short-term) and recombinant follicle stimulating hormone CO:COLLECTION_SUMMARY (FSH), tailored to their individual requirements. Follicular development and CO:COLLECTION_SUMMARY serum sex hormone levels (estradiol, progesterone) were monitored periodically CO:COLLECTION_SUMMARY throughout stimulation to assess response and adjust medication dosages as CO:COLLECTION_SUMMARY needed. Upon confirmation of at least two follicles exceeding 18 mm in diameter CO:COLLECTION_SUMMARY in the bilateral ovaries through ultrasound monitoring, 10,000 IU of human CO:COLLECTION_SUMMARY chorionic gonadotropin (HCG) was administered intramuscularly to trigger final CO:COLLECTION_SUMMARY oocyte maturation. Oocyte retrieval and FF aspiration were performed CO:COLLECTION_SUMMARY transvaginally under ultrasound guidance approximately 34-35 h post HCG CO:COLLECTION_SUMMARY injection. During the initial puncture of each follicle exceeding 18mm in CO:COLLECTION_SUMMARY diameter, approximately 1 mL of FF was collected in sterile 1.5mL vials CO:COLLECTION_SUMMARY (Tarsons, India) under ultrasound guidance and using a sterile aspiration CO:COLLECTION_SUMMARY needle. Care was taken to avoid blood contamination of the FF samples and CO:COLLECTION_SUMMARY contaminated samples, if any, were excluded. The samples were centrifuged at CO:COLLECTION_SUMMARY 12,000 rpm for 20 min at 4°C to eliminate cell debris, aliquoted and CO:COLLECTION_SUMMARY cryopreserved at -80°C until analysis. CO:COLLECTION_PROTOCOL_FILENAME Study_participants_and_Collection_protocol.pdf CO:SAMPLE_TYPE Follicular fluid #TREATMENT TR:TREATMENT_SUMMARY No experimental interventions were administered in this study; rather, we TR:TREATMENT_SUMMARY focused on the characterization of endogenous metabolic profiles present in the TR:TREATMENT_SUMMARY follicular fluid (FF) of the participants. This approach allowed us to TR:TREATMENT_SUMMARY investigate the metabolic landscape and its potential implications on TR:TREATMENT_SUMMARY reproductive health #SAMPLEPREP SP:SAMPLEPREP_SUMMARY To 40 µg of total protein from each FF sample (UI-and control-group), five SP:SAMPLEPREP_SUMMARY volumes of pre-chilled (-20°C) chloroform-methanol solution (2:1 v/v) was SP:SAMPLEPREP_SUMMARY added. The mixture was vigorously vortexed for 30 sec to ensure proper mixing SP:SAMPLEPREP_SUMMARY and then incubated overnight at 4°C to allow for complete protein precipitation SP:SAMPLEPREP_SUMMARY and metabolite partitioning. After overnight incubation, the samples were SP:SAMPLEPREP_SUMMARY centrifuged at 12,000 x g for 10 min at 4°C. The upper aqueous fraction, SP:SAMPLEPREP_SUMMARY enriched with hydrophilic metabolites, and the bottom chloroform fraction, SP:SAMPLEPREP_SUMMARY containing the hydrophobic metabolites, were carefully separated, vacuum dried, SP:SAMPLEPREP_SUMMARY and stored at −80°C until use (Nakayasu et al., 2016). Prior to LC-MS/MS SP:SAMPLEPREP_SUMMARY analysis, the dried samples were reconstituted in 20μL of a methanol-water SP:SAMPLEPREP_SUMMARY solution (1:1 v/v). Each reconstituted sample was then spiked with 2 ppm SP:SAMPLEPREP_SUMMARY reserpine (internal standard). SP:SAMPLEPREP_PROTOCOL_FILENAME Sample_prepartion_for_LCMSMS.pdf #CHROMATOGRAPHY CH:CHROMATOGRAPHY_SUMMARY Reversed-Phase Liquid Chromatography (RPLC) is a widely used chromatographic CH:CHROMATOGRAPHY_SUMMARY technique for the separation of nonpolar and moderately polar compounds based on CH:CHROMATOGRAPHY_SUMMARY their hydrophobicity. CH:CHROMATOGRAPHY_TYPE Reversed phase CH:INSTRUMENT_NAME Agilent 6550 CH:COLUMN_NAME Thermo Syncronis C-18 (150 x 4mm; 5um) CH:SOLVENT_A 100% water, 0.1% formic acid CH:SOLVENT_B 100% methanol; 0.1% formic acid CH:FLOW_GRADIENT Gradient for B:Gradient for B: time 0; 1%, 2min; 1%, 8min; 55%, 9min; 99%, CH:FLOW_GRADIENT 9.1min; 99%, 11min; 99%, 11.1min; 1%, 19min; 1%, 19.1min; 1%, 23min; 1% CH:FLOW_RATE 0.3 μL/min CH:COLUMN_TEMPERATURE 35 CH:METHODS_FILENAME LC-MSMS_protocol.pdf #ANALYSIS AN:ANALYSIS_TYPE MS AN:ANALYSIS_PROTOCOL_FILE LC-MSMS_Data_analysis.pdf #MS MS:INSTRUMENT_NAME Agilent 6550 QTOF MS:INSTRUMENT_TYPE QTOF MS:MS_TYPE ESI MS:ION_MODE POSITIVE MS:MS_COMMENTS Mass spectrometry acquisition was performed using an Agilent 6550 iFunnel Q-TOF MS:MS_COMMENTS LC/MS system in both positive and negative ionization modes, covering m/z 60 to MS:MS_COMMENTS 1000 at a scan rate of 1 spectrum per second. Data processing utilized XCMS MS:MS_COMMENTS Online (version 3.7.1) for feature identification and normalization, with raw MS:MS_COMMENTS files converted to .mzML format via ProteoWizard. Control and unexplained MS:MS_COMMENTS infertility (UI) group data in .mzML format were subsequently uploaded as MS:MS_COMMENTS separate datasets to XCMS Online for pairwise comparison. Differentially MS:MS_COMMENTS expressed metabolites in the follicular fluid (FF) were identified and forwaded MS:MS_COMMENTS through MetaboAnalyst's "MS Peaks to Pathways" function. The Mummichog algorithm MS:MS_COMMENTS was employed to identify enriched metabolic pathways using a p-value threshold MS:MS_COMMENTS of 0.001, with the KEGG database for Homo sapiens serving as the reference for MS:MS_COMMENTS metabolite annotation and pathway assignment. MS:MS_RESULTS_FILE ST003542_AN005816_Results.txt UNITS:Intensities Has m/z:Yes Has RT:Yes RT units:Minutes #END